Skip to main content
. 2015 Apr 8;194(10):4657–4667. doi: 10.4049/jimmunol.1403080

Table II. NK cell responses to vaccine Ags by HCMV status after adjusting for sex and age.

Adjusted for Sex and Age
Stimulus Parameter (Total NK Cells) Effect (95% CI)a pb
Pertussis CD25+ −4.4 (−8.3, −0.5) 0.014
CD25+IFN-γ+ −0.5 (−1.2, 0.3) 0.125
CD107a+ −1.5 (−3.4, 0.5) 0.071
Pertussis + LCC CD25+ −8.5 (−13.7, −3.4) 0.001
CD25+IFN-γ+ −1.5 (−2.8, −0.1) 0.020
CD107a+ −2.9 (−5.5, −0.3) 0.016
H1N1 CD25+ −5.4 (−9.5, −1.3) 0.005
CD25+IFN-γ+ −0.4 (−1.1, 0.4) 0.158
CD107a+ −1.8 (−3.9, 0.3) 0.049
H1N1 + LCC CD25+ −12.2 (−22.6, −1.8) 0.011
CD25+IFN-γ+ −5.1 (−10.4, 0.1) 0.027
CD107a+ −5.1 (−8.9, −1.5) 0.004
HCC CD25+ −11.3 (−16.7, −6.0) <0.0001
CD25+IFN-γ+ −6.5 (−11.4, −1.7) 0.005
CD107a+ −2.1 (−3.5, −0.6) 0.004

A regression analysis was performed in STATA to adjust for sex and age when comparing NK cell responses to pertussis (−/+ LCC), H1N1 (−/+ LCC), and HCC between HCMV and HCMV+ donors. The response was quantified by the percentage of total NK cells expressing CD25, CD25/IFN-γ (CD25+IFN-γ+), and CD107a.

a

Effect (coefficient), with 95% confidence interval (CI), represents the change in the mean percentage of NK cells responding in HCMV+ donors as compared with HCMV donors.

b

The p value refers to the significance of the difference in response between HCMV and HCMV+ donors after adjusting for sex and age. The p values < 0.05 are underlined.

HHS Vulnerability Disclosure